Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4589223014 | Bradophen | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4589226018 | Benzoxonium chloride | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4589227010 | Benzoxonium chloride (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Benzoxonium chloride | est un(e) (attribut) | Quaternary ammonium compound | true | Inferred relationship | Some | ||
| Benzoxonium chloride | est un(e) (attribut) | Anti-infective agent (substance) | true | Inferred relationship | Some | ||
| Benzoxonium chloride | Is modification of (attribute) | Benzoxonium | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely benzoxonium chloride 1 milligram and lidocaine hydrochloride 1 milligram/1 each conventional release chewable tablet (clinical drug) | Has precise active ingredient | True | Benzoxonium chloride | Inferred relationship | Some | 1 |
| Product containing precisely benzoxonium chloride 1 milligram and lidocaine hydrochloride 1 milligram/1 each conventional release chewable tablet (clinical drug) | Has basis of strength substance (attribute) | True | Benzoxonium chloride | Inferred relationship | Some | 1 |
Reference Sets
FHIR